Parathyroid Hormone Levels and High ‐Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor

ConclusionIn patients receiving dual antiplatelet therapy for coronary artery disease, higher PTH levels are associated with an increased ADP‐mediated platelet reactivity and suboptimal response to clopidogrel, especially for values above 96.7 pg/mL, while not influencing the effectiveness of ASA and ticagrelor.

Source: Cardiovascular Therapeutics - July 5, 2016 Category: Cardiology Authors: Monica Verdoia, Patrizia Pergolini, Roberta Rolla, Matteo Nardin, Lucia Barbieri, Alon Schaffer, Giorgio Bellomo, Paolo Marino, Harry Suryapranata, Giuseppe De Luca, Tags: Original Research Article Source Type: research